Summary
Recent methodologies used in preparing anaphylatoxins from complement-activated serum are described. Activation of the alternative pathway generates C3a and C5a; however, activation of the classical pathway is required to generate the anaphylatoxin from C4. This article describes an activation scheme that simultaneously generates all three of the anaphylatoxins (e.g., C3a, C4a and C5a) in human serum and outlines a procedure for isolating each as homogeneous products. Purification of intact anaphylatoxins directly from complement-activated serum takes place only if an exopeptidase in serum, known as carboxypeptidase N (SCPN), is properly inhibited. A new series of mercapto derivatives of arginine analogs are introduced as potent and effective inhibitors of SCPN. These inhibitors permit normal complement activation but prevent degradation of the released activation fragments C3a, C4a or C5a.
The SCPN inhibitor previously used was 6-aminohexanoic acid (EACA), but it required a 1 M concentration for effective inhibition, the substituted mercapto-guanido compounds prove to be effective in the mM range.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hugli, T.E., 1981. CRC Critical Reviews in Immunology. 1: 321–366.
Gorski, J.P., Hugli, T.E., & Müller-Eberhard, H.J., 1979. Proc. Natl. Acad. Sci. USA. 76: 5299–5302.
Gorski, J.P., Hugli, T.E., & Mülle-Eberhard, H.J., 1981. J. Biol. Chem. 256: 2707–2711.
Hugli, T.E., & Müller-Eberhard, H.J., 1978. Adv. Immunol. 26: 1–53.
Jensen, J.A., 1972. In Biological Activities of Complement, (Ingram, D.G. Ed.), S. Krager, Basel, pp. 136–157.
Fernandez, H.N., Henson, P.M., Otani, A., & Hugli, T.E., 1978. J. Immunol. 120: 109–115.
Stimler, N.P., Brocklehurst, W.E., Bloor, C.M., & Hugli, T.E., 1980. J. Pharm. Pharmacol. 32: 804.
Stimler, N.P., Brocklehurst, W.E., Bloor, C.M., & Hugli, T.E., 1981. J. Immunol., in press.
Orr, W., Varani, J., & Ward, P.A., 1978. Am. J. Pathol., 93: 405–422.
Orr, W., Phan, S.H., Varani, J., Ward, P.A., Kreutzer, D.L., Webster, R.O., & Henson, P.M., 1979. Proc. Natl. Acad. Sci. USA, 76: 1986–1989.
Ondetti, M.A., Condon, M.E., Reid, J., Sabo, E.G., Cheung, H.S., & Cushman, D.W., 1979. Biochemistry 18: 1427–1430.
Plummer, T.H. Jr., & Ryan, T.J., 1981. Biochem. Biophys. Res. Commun. 98: 448–454.
Hugli, T.E., Vallota, E.H., & Müller-Eberhard, H.J., 1975. J. Biol. Chem. 250: 1472–1478.
Fernandez, H.N., & Hugli, T.E., 1976. J. Immunol. 117: 1688–1694.
Gerard, C., & Hugli, T.E., 1979. J. Biol. Chem. 254: 6346–6351.
Mathews, K.P., Pan, P.M., Gardner, H.J., & Hugli, T.E., 1980. Annals Intern. Med. 93: 443–445.
McKay, T.J., & Plummer, T.H. Jr., 1978. Biochemistry 17: 401–405.
Gerard, C., & Hugli, T.E., 1981. Proc. Natl. Acad. Sci., USA 78: 1833–1837.
Hugli, T.E., & Chenoweth, D.E., 1980. In Immunoassays: Clinical Laboratory Techniques for the 1980’s, Alan R. Liss, Inc., New York, NY pp. 443–460.
Cochrane, C.G., & Müller-Eberhard, H.J., 1968. J. Exp. Med. 127: 371–386.
Curd, J.G., Chenoweth, D.E., & Hugli, T.E., 1980. J. Immunol. 124: 1517 (Abstract).
Chenoweth, D.E., Cooper, S.W., Hugli, T.E., Stewart, R.W., Blackstone, E.H., & Kirklin, J.W., 1981. N. Engl. J. Med. 304: 497–503.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1981 Martinus Nijhoff/ Dr W. Junk Publishers, The Hague
About this chapter
Cite this chapter
Hugli, T.E. et al. (1981). Isolation of three separate anaphylatoxins from complement-activated human serum. In: Najjar, V.A. (eds) Immunologically Active Peptides. Developments in Molecular and Cellular Biochemistry, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8030-3_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-8030-3_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8032-7
Online ISBN: 978-94-009-8030-3
eBook Packages: Springer Book Archive